Search
for

    Did you mean Upper Respiratory Infections?
    Glossary Upper Respiratory Infections

    infections affecting the nose, throat, and sinuses

    Upper Respiratory Infections (URIs) refer to infections that affect the upper part of the respiratory system, which includes the nose, throat, and sinuses. Common examples include the common cold, sinusitis, and laryngitis. These infections are typically caused by viruses and can lead to symptoms such as a runny nose, sore throat, cough, and congestion.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients Journal of The American Academy of Dermatology · 2016 · 238 citations
    2. Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta‐analysis Journal of the European Academy of Dermatology and Venereology · 2019 · 54 citations
    3. Tofacitinib therapy for children with severe alopecia areata Journal of the American Academy of Dermatology · 2019 · 39 citations
    4. Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients Dermatologic Therapy · 2019 · 17 citations
    5. Response of alopecia areata of the beard to oral tofacitinib Journal of the American Academy of Dermatology · 2019 · 11 citations
    6. Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review 2023 · 2 citations
    7. Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata Dermatologic therapy · 2024
    8. BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience British Journal of Dermatology · 2023
    9. Safety and efficacy of tofacitinib in 97 alopecia areata patients Journal of cosmetic dermatology · 2024
    10. 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects Journal of Investigative Dermatology · 2023
    11. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2) American Journal of Clinical Dermatology · 2023 · 20 citations
    12. Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review Clinical drug investigation · 2023 · 3 citations
    13. ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW International Journal of Innovative Technologies in Social Science · 2025
    14. Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials 2022 · 25 citations
    15. Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata Dermatologic Therapy · 2019 · 9 citations
    16. Baricitinib for the Treatment of Alopecia Areata Drugs · 2023 · 6 citations
    17. Treatment of chronic alopecia areata with tildrakizumab: an open‐label pilot study International Journal of Dermatology · 2020 · 3 citations
    18. Adverse effects of baricitinib in comparison to methotrexate in the treatment of severe alopecia areata International Journal of Research in Medical Sciences · 2026
    19. EPH39 Alopecia Areata: Targeted Review of Adverse Events Associated with Clinical Studies of Treatments Value in Health · 2023
    20. Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata The Open Dermatology Journal · 2023
    21. Zinc in hair and urine of paediatric patients Clinica Chimica Acta · 1986 · 16 citations
    22. COVID-19 VIRUS-POSITIVE PATIENTS AFTER LARINGECTOMY: TREATMENT IN A HOSPITAL Голова и шея. · 2022
    23. NEUROMA DE NERVO RADIAL APÓS CORREÇÃO CIRÚRGICA DA LESÃO SECUNDÁRIA DE FRATURA DIAFISÁRIA DE ÚMERO Brazilian Journals Editora eBooks · 2023
    24. Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID ‐19 Clinical Case Reports · 2022 · 2 citations
    25. Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity Orphanet journal of rare diseases · 2021 · 11 citations
    26. Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity Research Square (Research Square) · 2021
    27. Classic Sweet sydrome: A case report Journal of The American Academy of Dermatology · 2018
    28. JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study Dermatology and Therapy · 2026 · 1 citations
    29. Efficacy and safety of tofacitinib in patients with alopecia areata Journal of Pakistan Association of Dermatologists · 2026
    30. Dupilumab: A Potential Option for Young Children With Alopecia Areata and Atopic Features Dermatologic Therapy · 2026